Objective: To evaluate for drugs with superior neuroprotective efficacy and investigate their underlying mechanisms related to antioxidation.
Procedures: Brinzolamide (1%), timolol (0.5%), minocycline (22 mg/kg), lidocaine (1.5 mg/kg), and methylprednisolone (30 mg/kg) were administered to Sprague-Dawley (SD) rats. The retina was evaluated by electroretinography and histological analysis. The antioxidative capacity of drugs was evaluated to clarify the underlying mechanism. The oxidant/antioxidant profiles of plasma, red blood cells, and retina were analyzed by lipid peroxidation (malondialdehyde) and by measuring the activities of antioxidants. Proteomic analysis was used to investigate the possible protective mechanisms of the drug against ischemia-reperfusion injury.
Results: The results suggested that timolol, methylprednisolone, and minocycline protected retinal function. Methylprednisolone and minocycline possessed good antioxidative activity. Brinzolamide and lidocaine preserved the structural integrity of the retina, but not retinal function.
Conclusion: Methylprednisolone, minocycline, and timolol have potential acute or delayed benefit in retinal ischemia-reperfusion injury. Their neuroprotective actions depend at least partially on the ability to alleviate oxidative stress.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/vop.12105 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diffuse Alveolar Hemorrhage Due to Macrolide-Refractory Mycoplasma pneumoniae Diagnosed by FilmArray Analysis of Bronchoalveolar Lavage Fluid.
Cureus
December 2024
Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, JPN.
typically causes mild respiratory infections but can rarely lead to severe complications. We report a case of a 43-year-old immunocompetent male who presented with progressive dyspnea and respiratory failure with bilateral pulmonary infiltrates, refractory to outpatient treatment with azithromycin, ceftriaxone, and levofloxacin. Bronchoscopy revealed multiple white plaques in the trachea and diffuse alveolar hemorrhage.
View Article and Find Full Text PDFChallenges in the treatment of pediatric Mycoplasma pneumoniae pneumonia.
Eur J Pediatr
July 2024
Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.
Article Synopsis
- Mycoplasma pneumoniae (MP) is a key cause of community-acquired pneumonia in children and adolescents, and while macrolide antibiotics are generally effective, treatment failures can occur, leading to severe health complications.
- Resistance to macrolides is a significant issue, especially in East Asia, requiring alternative treatments like tetracyclines and fluoroquinolones for those affected by macrolide-resistant pneumonia.
- Immunomodulators such as corticosteroids and IVIG have shown promise in treating severe cases, particularly when combined with the right antibiotics, but some patients may still experience persistent symptoms despite treatment.
An updated systematic review of neuroprotective agents in the treatment of spinal cord injury.
Neurosurg Rev
March 2024
Mansoura Manchester Program for Medical Education, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
This systematic review aims to summarize the findings from all clinical randomized trials assessing the efficacy of potential neuroprotective agents in influencing the outcomes of acute spinal cord injuries (SCI). Following the PRISMA guidelines, we conducted comprehensive searches in four electronic databases (PubMed, Scopus, Cochrane Library, and Web of Science) up to September 5th, 2023. Our analysis included a total of 30 studies.
View Article and Find Full Text PDFCase Report: Minocycline-induced drug reaction with eosinophilia and systemic symptoms syndrome: a case report and literature review.
Front Pharmacol
March 2024
Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Minocycline is a tetracycline commonly used for several dermatological diseases. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare but severe adverse event which can be caused by minocycline. An 18-year-old male patient developed fever, acute rash, pharyngeal pain, lymphadenopathy, hematologic abnormalities, increased creatinine level, elevated liver enzyme levels, and splenomegaly 4 weeks after the oral treatment of minocycline, 100 mg daily, for acne.
View Article and Find Full Text PDFAn update on combination therapies for multiple sclerosis: where are we now?
Expert Rev Neurother
December 2023
Danish Multiple Sclerosis Center, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark.
Introduction: In theory, combination of two agents, which are suboptimal when given individually, may result in a significant increase in therapeutic effect. Combination therapies have proven particularly effective against infections such as HIV, cancer, and also chronic autoimmune diseases such as rheumatoid arthritis.
Areas Covered: The authors review the literature, searching for randomized placebo-controlled or comparative, double-blind or investigator-blinded clinical trials, not including open label clinical trials, of treatment of multiple sclerosis (MS) with combination therapy or add-on therapy, including trials of induction therapy, trials for prevention of disease activity or worsening, amelioration of adverse effects, and treatment of relapses, and trials to increase remyelination.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!